Although a vaccine against SARS-CoV-2 Omicron-XBB.1.5 variant is available worldwide and recent infection is protective, the lack of recorded infection data highlights the need to assess variant-specific antibody neutralization levels. We analyzed IgG levels against receptor-binding domain–specific SARS-CoV-2 ancestral strain as a correlate for high neutralizing titers against XBB variants.
All Keywords
【저자키워드】 COVID-19, viruses, respiratory infections, antibodies, SARS-CoV-2, IgG, Vaccines, Neutralizing antibodies, Israel, vaccine-preventable diseases, XBB variant,
【저자키워드】 COVID-19, viruses, respiratory infections, antibodies, SARS-CoV-2, IgG, Vaccines, Neutralizing antibodies, Israel, vaccine-preventable diseases, XBB variant,